NZ703345A - Compositions and methods for reducing frequency and/or severity of headache - Google Patents

Compositions and methods for reducing frequency and/or severity of headache

Info

Publication number
NZ703345A
NZ703345A NZ703345A NZ70334513A NZ703345A NZ 703345 A NZ703345 A NZ 703345A NZ 703345 A NZ703345 A NZ 703345A NZ 70334513 A NZ70334513 A NZ 70334513A NZ 703345 A NZ703345 A NZ 703345A
Authority
NZ
New Zealand
Prior art keywords
headache
severity
subject
frequency
reducing
Prior art date
Application number
NZ703345A
Other languages
English (en)
Inventor
Ralph Bright
Pelin Bright
Bruce Hansen
Wayne Thomas
Original Assignee
Rusty Property Holdings Pty Ltd
Amberdale Entpr Pty Ltd
Tavid Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012902720A external-priority patent/AU2012902720A0/en
Application filed by Rusty Property Holdings Pty Ltd, Amberdale Entpr Pty Ltd, Tavid Pty Ltd filed Critical Rusty Property Holdings Pty Ltd
Publication of NZ703345A publication Critical patent/NZ703345A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vascular Medicine (AREA)
NZ703345A 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache NZ703345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012902720A AU2012902720A0 (en) 2012-06-26 Compositions and methods for reducing frequency and/or severity of headache
PCT/AU2013/000684 WO2014000029A1 (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Publications (1)

Publication Number Publication Date
NZ703345A true NZ703345A (en) 2017-03-31

Family

ID=49781943

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ703345A NZ703345A (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Country Status (9)

Country Link
US (1) US10206956B2 (https=)
EP (1) EP2863927A4 (https=)
JP (1) JP2015521630A (https=)
KR (1) KR20150091037A (https=)
CN (1) CN104902909A (https=)
AU (1) AU2013284338B2 (https=)
CA (1) CA2877022A1 (https=)
NZ (1) NZ703345A (https=)
WO (1) WO2014000029A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160120909A1 (en) * 2013-05-10 2016-05-05 Cell-Innovations Ip Pty Ltd Compositions And Methods For The Treatment Of Tinnitus
US20150005234A1 (en) * 2013-07-01 2015-01-01 Amit Prakash Govil Soft tissue implant
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
JP6829225B2 (ja) * 2018-06-13 2021-02-10 株式会社 バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物
CN110772535A (zh) * 2018-07-12 2020-02-11 南通大学 多系分化持续应激细胞在制备镇痛药物中的应用
JP6497827B1 (ja) * 2018-07-17 2019-04-10 株式会社 バイオミメティクスシンパシーズ エイコサノイド産生促進剤
EP3847241A1 (en) 2018-10-26 2021-07-14 Stemselect Method and apparatus for mesenchymal stem cells isolation and purification
IL302833A (en) * 2020-11-13 2023-07-01 Advanced Therapeutic Lab Inc Medicinal compositions and methods using SVF derived from adipose tissue

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0008552A (pt) 1999-03-10 2002-05-07 Univ Pittsburgh Células tronco e redes derivadas de tecido adiposo
KR20050044393A (ko) * 2001-11-09 2005-05-12 아르테셀 사이언스, 인크. 지방 조직 유래된 스트로마 세포의 내분비 췌장 분화 및이의 용도
WO2005013885A2 (en) * 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
JP2007508018A (ja) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
JP2010037292A (ja) 2008-08-06 2010-02-18 Univ Of Tokyo 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法
KR20200011604A (ko) 2008-08-20 2020-02-03 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
CA2734237C (en) 2008-08-20 2019-07-02 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
EP2379087B1 (en) * 2008-12-19 2014-08-20 DePuy Synthes Products, LLC Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
AU2009100401A4 (en) * 2009-04-30 2009-06-04 Gl Holdings Inc Bv Method of extracting and activating adipose-derived stem cells
KR101738324B1 (ko) * 2009-05-01 2017-05-19 비미니 테크놀로지스 엘엘씨 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물
JP2011010581A (ja) 2009-06-30 2011-01-20 Kaneka Corp 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法
JP5905446B2 (ja) 2010-03-24 2016-04-20 ライフネット ヘルス Ｂｍｐ−４ペプチドおよび使用方法
AU2011249406B2 (en) * 2010-05-06 2015-05-14 Stem Cell Medicine Ltd. Stem cell bank for personalized medicine
US20120156230A1 (en) * 2010-12-17 2012-06-21 Abbot Stewart Treatment of spinal cord injury and traumatic brain injury using placental stem cells
NZ612801A (en) * 2010-12-27 2014-12-24 Intellicell Biosciences Inc Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
KR101903339B1 (ko) * 2011-03-22 2018-10-01 플루리스템 리미티드 방사선 또는 화학적 손상을 치료하는 방법
ES2707579T3 (es) * 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
JP5598864B2 (ja) 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬

Also Published As

Publication number Publication date
US10206956B2 (en) 2019-02-19
CN104902909A (zh) 2015-09-09
EP2863927A1 (en) 2015-04-29
KR20150091037A (ko) 2015-08-07
WO2014000029A1 (en) 2014-01-03
CA2877022A1 (en) 2014-01-03
EP2863927A4 (en) 2015-12-02
US20150174172A1 (en) 2015-06-25
AU2013284338A1 (en) 2015-01-22
AU2013284338B2 (en) 2018-03-01
JP2015521630A (ja) 2015-07-30

Similar Documents

Publication Publication Date Title
NZ703345A (en) Compositions and methods for reducing frequency and/or severity of headache
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MY178152A (en) Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
MX390739B (es) Composicion de hueso comprimido y metodo para usar la misma.
MX381456B (es) Regulador de ph de transduccion.
SG10201901713RA (en) Extracellular matrix compositions
WO2014058804A3 (en) Micronized compositions composed of bone grafts and methods of making and using the same
HK1212239A1 (en) Methods for prevention and treatment of preeclampsia
UA116088C2 (uk) Спосіб та композиція для боротьби з бур'янами (варіанти)
IN2015DN03322A (https=)
PH12015502289A1 (en) Creamer composition comprising plant protein microparticles
WO2011159770A3 (en) Methods and compositions for promoting hair growth
WO2012168410A3 (en) Methods for treating lignocellulosic material
BR112016030758B8 (pt) Uso de células estromais multipotentes derivadas de tecido adiposo mesenquimal
PH12015502405B1 (en) Methods and compositions for wound healing
SMT201900426T1 (it) Sigillante di tessuto in cui collagene e fibrina sono miscelati e metodo per preparare lo stesso
IL274538B (en) A preparation containing mesenchymal stem cells for tissue regeneration and a method for its production
MX2016016756A (es) Terapia con células madre en patologías endometriales.
MX2014006337A (es) Composiciones de proteina del gen 3 de bacteriofago y sus usos como agentes de union amiloides.
HK1202375A1 (en) Skin lightening compositions
MX367393B (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX358132B (es) Solucion de trombina y metodos de uso de esta.
WO2012119103A3 (en) Compositions and methods for mobilization of stem cells
PH12012501548A1 (en) Compositions comprising sugar-cysteine products
EP2902413A4 (en) POLYPEPTIDE, FRUIT COMPOSITION, COMPOSITION FOR CARTILAGE RANGE TESTING, COMPOSITION FOR CORTIC CELL CULTURE AND COMPOSITION FOR PROMOTING GLYCOSAMINOGLYCAN PRODUCTION